Michelle L Schoettler (Michelle Schoettler)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Sickle Cell Disease

Respiratory Syncytial Virus

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

British journal of haematology

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Satheesh Chonat, Kirsten M Williams, Wendy B London, Christine Duncan, Christopher E Dandoy
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood advances 8 (5) (2024)
Michelle L Schoettler, Kaley French, Anora Harris, Elyse Bryson, Laura Deeb, Zuri Hudson, Jeremy Obordo, Shanmuganathan Chandrakasan, Suhag Parikh, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Jeffrey Switchenko, Kirsten M Williams
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology 99 (3) (2024)
Michelle L Schoettler, Kaley French, Anora Harris, Elyse Bryson, Laura Deeb, Zuri Hudson, Jeremy Obordo, Shanmuganathan Chandrakasan, Suhag Parikh, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Jeffrey Switchenko, Kirsten M Williams
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology 99 (3) (2024)
Michelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Satheesh Chonat, Kirsten M Williams, Wendy B London, Christine Duncan, Christopher E Dandoy
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood advances 8 (5) (2024)
Michelle L Schoettler, Kaley French, Anora Harris, Elyse Bryson, Laura Deeb, Zuri Hudson, Jeremy Obordo, Shanmuganathan Chandrakasan, Suhag Parikh, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Jeffrey Switchenko, Kirsten M Williams
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology (2024)
Michelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Satheesh Chonat, Kirsten M Williams, Wendy B London, Christine Duncan, Christopher E Dandoy
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood advances 8 (5) (2024)
Michelle L Schoettler, Adrianna Westbrook, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Kirsten M Williams
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis. British journal of haematology 205 (1) (2024)
Michelle L Schoettler, Adrianna Westbrook, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Kirsten M Williams
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis. British journal of haematology (2024)
Michelle L Schoettler, Kaley French, Anora Harris, Elyse Bryson, Laura Deeb, Zuri Hudson, Jeremy Obordo, Shanmuganathan Chandrakasan, Suhag Parikh, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Jeffrey Switchenko, Kirsten M Williams
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology 99 (3) (2024)
Sharmila Raghunandan, Lev Gorfinkel, Michael Graiser, Brandi Bratrude, Yvonne Suessmuth, Scott Gillespie, Adrianna L Westbrook, Kirsten M Williams, Michelle L Schoettler, Leslie S Kean, John T Horan, Amelia A Langston, Muna Qayed, Benjamin Watkins
Abatacept for The Prevention of GVHD in Patients Receiving Mismatched Unrelated Transplants: A Real-World Analysis. Blood advances (2023)
Michelle L Schoettler, Leslie Elaine Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Satheesh Chonat, Kirsten M Williams, Wendy B London, Christine Duncan, Christopher E Dandoy
Pediatric Transplant Associated Thrombotic Microangiopathy Healthcare Utilization and Implications of Eculizumab Therapy. Blood advances (2023)
Sanyukta Janardan, Edwin M Horwitz, Benjamin Watkins, Kirsten Williams, Shanmuganathan Chandrakasan, Muna Qayed, Suhag H Parikh, Staci D Arnold, Frank Keller, Adina Alazraki, Michelle L Schoettler, Kathryn Leung
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood advances 6 (10) (2022)
Michelle L Schoettler, Elizabeth O Stenger, Kathleen Spencer, Deborah Lutterman, Savanah Rumbika, Jayre A Jones, Ann E Haight, Suhag H Parikh, Muna Qayed, Benjamin Watkins, Krishnamurti Lakshmanan, Kirsten M Williams, Satheesh Chonat
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood advances (2022)
Michelle L Schoettler, Christine Duncan, Leslie Lehmann
Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab. Pediatric transplantation 23 (3) (2019)
Michelle L Schoettler, Christine Duncan, Leslie Lehmann, Elissa Furutani, Meera Subramaniam, Steven Margossian
Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation. Bone marrow transplantation 54 (7) (2019)